maximum dose of bpc 157 BPC-157 Dosage Guide: Protocols & Safety 2026 max dose of bpc 157

Technique Ultrasound-guided approach (preferred) Local Corticosteroid Injection at tendon sheath under Ultrasound guidance (see Shoulder Ultrasound) Approached in-plane to linear Ultrasound probe (probe short axis to anterior Shoulder - home position) Do not inject within tendon (and avoid circumflex artery within groove) Technique Landmark-based approach Images Landmarks Identify bicipital tendon in bicipital groove (proximal Humerus) Mark point of maximal tenderness over groove Injected with sterile technique (with Betadine preparation of skin) Direct needle parallel to bicipital groove (vertically oriented) Needle enters skin at 30 degrees oriented superiorly Do not inject bicipital tendon Infiltrate area around groove, but not into tendon Flow resisted when needle is inside tendon Withdraw needle slightly and retry Continue to withdraw until not in tendon Complications Bicipital tendon rupture Associated with intratendinous injection Do not inject bicipital tendon References

Retatrutide remains in clinical development and is not approved for general prescribing or self-administration in the UK

Early treatment with DMARDs (like methotrexate or biologics) helps calm the immune system and prevent long-term damage

Q: Can it be combined with other therapies

BPC-157, short for Body Protection Compound-157, is a derivative of body protection compound (BPC)